Muscarinic acetylcholine receptor M2 explained

The muscarinic acetylcholine receptor M2, also known as the cholinergic receptor, muscarinic 2, is a muscarinic acetylcholine receptor that in humans is encoded by the CHRM2 gene.[1] Multiple alternatively spliced transcript variants have been described for this gene.[1] It is Gi-coupled, reducing intracellular levels of cAMP.

Function

Heart

The M2 muscarinic receptors are located in the heart, where they act to slow the heart rate down to normal sinus rhythm after negative stimulatory actions of the parasympathetic nervous system, by slowing the speed of depolarization. They also reduce contractile forces of the atrial cardiac muscle, and reduce conduction velocity of the atrioventricular node (AV node). However, they have little effect on the contractile forces of the ventricular muscle, slightly decreasing force.

Airway smooth muscle

Both M2 and M3 muscarinic receptors are expressed in the smooth muscles of the airway, with the majority of the receptors being the M2 type. Activation of the M2 receptors, which are coupled to Gi, inhibits the β-adrenergic mediated relaxation of the airway smooth muscle. Synergistically, activation of the M3 receptors, which couple to Gq, stimulates contraction of the airway smooth muscle.[2]

IQ

A Dutch family study found that there is "a highly significant association" between the CHRM2 gene and intelligence as measured by the Wechsler Adult Intelligence Scale-Revised.[3] A similar association was found independently in the Minnesota Twin and Family Study.[4] [5]

However, a larger 2009 study attempting to replicate this claim instead found no significant association between the CHRM2 gene and intelligence.[6]

Olfactory behavior

Mediating olfactory guided behaviors (e.g. odor discrimination, aggression, mating).[7]

Mechanism of action

M2 muscarinic receptors act via a Gi type receptor, which causes a decrease in cAMP in the cell, generally leading to inhibitory-type effects. They appear to generally serve as autoreceptors.[8]

In addition, they modulate G protein-coupled inwardly-rectifying potassium channels.[9] [10] In the heart, this contributes to a decreased heart rate. They do so by the Gβγ subunit of the G protein; Gβγ shifts the open probability of K+ channels in the membrane of the cardiac pacemaker cells, which causes an outward current of potassium, effectively hyperpolarizing the membrane, which slows down the heart rate.

Ligands

Few highly selective M2 agonists are available at present, although there are several non-selective muscarinic agonists that stimulate M2, and a number of selective M2 antagonists are available.

Agonists

Antagonists

See also

Further reading

External links

Notes and References

  1. Web site: Entrez Gene: CHRM2 cholinergic receptor, muscarinic 2.
  2. Hirshman CA, Lande B, Croxton TL . Role of M2 muscarinic receptors in airway smooth muscle contraction . Life Sciences . 64 . 6–7 . 443–448 . January 1999 . 10069508 . 10.1016/S0024-3205(98)00586-4 . free .
  3. Gosso MF, van Belzen M, de Geus EJ, Polderman JC, Heutink P, Boomsma DI, Posthuma D . Association between the CHRM2 gene and intelligence in a sample of 304 Dutch families . Genes, Brain and Behavior . 5 . 8 . 577–584 . November 2006 . 17081262 . 10.1111/j.1601-183X.2006.00211.x . free .
  4. Comings DE, Wu S, Rostamkhani M, McGue M, Lacono WG, Cheng LS, MacMurray JP . Role of the cholinergic muscarinic 2 receptor (CHRM2) gene in cognition . Molecular Psychiatry . 8 . 1 . 10–11 . January 2003 . 12556901 . 10.1038/sj.mp.4001095 . 22314941 .
  5. Dick DM, Aliev F, Kramer J, Wang JC, Hinrichs A, Bertelsen S, Kuperman S, Schuckit M, Nurnberger J, Edenberg HJ, Porjesz B, Begleiter H, Hesselbrock V, Goate A, Bierut L . 6 . Association of CHRM2 with IQ: converging evidence for a gene influencing intelligence . Behavior Genetics . 37 . 2 . 265–272 . March 2007 . 17160701 . 10.1007/s10519-006-9131-2 . 9353852 .
  6. Lind PA, Luciano M, Horan MA, Marioni RE, Wright MJ, Bates TC, Rabbitt P, Harris SE, Davidson Y, Deary IJ, Gibbons L, Pickles A, Ollier W, Pendleton N, Price JF, Payton A, Martin NG . 6 . No association between Cholinergic Muscarinic Receptor 2 (CHRM2) genetic variation and cognitive abilities in three independent samples . Behavior Genetics . 39 . 5 . 513–523 . September 2009 . 19418213 . 10.1007/s10519-009-9274-z . 2523697 .
  7. Smith RS, Hu R, DeSouza A, Eberly CL, Krahe K, Chan W, Araneda RC . Differential Muscarinic Modulation in the Olfactory Bulb . The Journal of Neuroscience . 35 . 30 . 10773–10785 . July 2015 . 26224860 . 4518052 . 10.1523/JNEUROSCI.0099-15.2015 .
  8. Douglas CL, Baghdoyan HA, Lydic R . M2 muscarinic autoreceptors modulate acetylcholine release in prefrontal cortex of C57BL/6J mouse . The Journal of Pharmacology and Experimental Therapeutics . 299 . 3 . 960–966 . December 2001 . 11714883 .
  9. Book: Rang HP . Pharmacology . Churchill Livingstone . Edinburgh . 2003 . 0-443-07145-4 .
  10. Book: Boron WF, Boulpaep EL . Medical Physiology . Elsevier Saunders . Philadelphia . 2005 . 387 . 1-4160-2328-3 .
  11. Scapecchi S, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Martelli C, Manetti D, Martini E, Marucci G, Nesi M, Romanelli MN, Teodori E, Gualtieri F . 6 . Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist . Journal of Medicinal Chemistry . 49 . 6 . 1925–1931 . March 2006 . 16539379 . 10.1021/jm0510878 .
  12. Matera C, Flammini L, Quadri M, Vivo V, Ballabeni V, Holzgrabe U, Mohr K, De Amici M, Barocelli E, Bertoni S, Dallanoce C . 6 . Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity . European Journal of Medicinal Chemistry . 75 . 222–232 . March 2014 . 24534538 . 10.1016/j.ejmech.2014.01.032 .
  13. Cristofaro I, Spinello Z, Matera C, Fiore M, Conti L, De Amici M, Dallanoce C, Tata AM . 6 . Activation of M2 muscarinic acetylcholine receptors by a hybrid agonist enhances cytotoxic effects in GB7 glioblastoma cancer stem cells . Neurochemistry International . 118 . 52–60 . September 2018 . 29702145 . 10.1016/j.neuint.2018.04.010 . 207125517 .
  14. Bock A, Merten N, Schrage R, Dallanoce C, Bätz J, Klöckner J, Schmitz J, Matera C, Simon K, Kebig A, Peters L, Müller A, Schrobang-Ley J, Tränkle C, Hoffmann C, De Amici M, Holzgrabe U, Kostenis E, Mohr K . 6 . The allosteric vestibule of a seven transmembrane helical receptor controls G-protein coupling . Nature Communications . 3 . 1044 . 2012-09-04 . 22948826 . 3658004 . 10.1038/ncomms2028 . 2012NatCo...3.1044B .
  15. Riefolo F, Matera C, Garrido-Charles A, Gomila AM, Sortino R, Agnetta L, Claro E, Masgrau R, Holzgrabe U, Batlle M, Decker M, Guasch E, Gorostiza P . 6 . Optical Control of Cardiac Function with a Photoswitchable Muscarinic Agonist . Journal of the American Chemical Society . 141 . 18 . 7628–7636 . May 2019 . 31010281 . 10.1021/jacs.9b03505 . free . 128361100 . 2445/147236 .
  16. Melchiorre C, Angeli P, Lambrecht G, Mutschler E, Picchio MT, Wess J . Antimuscarinic action of methoctramine, a new cardioselective M-2 muscarinic receptor antagonist, alone and in combination with atropine and gallamine . European Journal of Pharmacology . 144 . 2 . 117–124 . December 1987 . 3436364 . 10.1016/0014-2999(87)90509-7 .